Reporting of all cardiac medications and their outcome in COVID-19.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

11 citing papers in PubMed.

1. Evaluation of the effectiveness and safety of adding ivermectin to treatment in severe COVID-19 patients.BMC infectious diseases · 2021
   Trial
2. Mechanism and potential treatments for gastrointestinal dysfunction in patients with COVID-19.World journal of gastroenterology · 2022
   Review
3. Infective endocarditis and COVID -19 coinfection: An updated review.Acta bio-medica : Atenei Parmensis · 2022
   Review
4. Electrocardiographic Findings and Clinical Outcome in Patients with COVID-19 or Other Acute Infectious Respiratory Diseases.Journal of clinical medicine · 2020
   Article
5. Current Perspectives of convalescent plasma therapy in COVID-19.Acta bio-medica : Atenei Parmensis · 2020
   Review
6. An Update on Pulmonary Hypertension in Coronavirus Disease-19 (COVID-19).Acta bio-medica : Atenei Parmensis · 2020
   Review
7. Letter to the Editor Regarding "Acute Stroke Management During the Coronavirus Disease 2019 (COVID-19) Pandemic: From Trough of Disillusionment to Slope of Enlightenment".World neurosurgery · 2020
   Article
8. Letter to the Editor Regarding "Neurological Impact of Coronavirus Disease (COVID-19): Practical Considerations for the Neuroscience Community".World neurosurgery · 2020
   Article
9. Trajectory of the COVID-19 pandemic: chasing a moving target.Annals of translational medicine · 2020
   Review
10. India Fights Back: COVID-19 Pandemic.Heart & lung : the journal of critical care
    Article
11. A review of cardiac manifestations and predictors of outcome in patients with COVID - 19.Heart & lung : the journal of critical care
    Review

Corrections and comments

• Commented on by
  Reply to: "Reporting of all cardiac medications and their outcome in COVID-19".2020
• Comment on
  Organ-protective effect of angiotensin-converting enzyme 2 and its effect on the prognosis of COVID-19.2020

Authors and funding

3 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as